170011-56-0

Basic information

• Product Name: 1-Boc-4-(4-nitrophenyl)Piperidine
• Synonyms: 1-Boc-4-(4-nitrophenyl)Piperidine;1-Piperidinecarboxylic acid, 4-(4-nitrophenyl)-, 1,1-dimethylethyl ester
• CAS NO: 170011-56-0
• Molecular Formula: C₁₆H₂₂N₂O₄
• Molecular Weight: 306.35688
• Mol File: 170011-56-0.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1-Boc-4-(4-nitrophenyl)Piperidine(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Boc-4-(4-nitrophenyl)Piperidine(170011-56-0)
• EPA Substance Registry System: 1-Boc-4-(4-nitrophenyl)Piperidine(170011-56-0)

Safety Data

• Hazardous Substances Data: 170011-56-0(Hazardous Substances Data)

Usage

Molecular Structure

A piperidine ring with a 4-nitrophenyl group attached, and a Boc protecting group attached to the piperidine nitrogen.

Usage

As a building block in the synthesis of pharmaceuticals and other organic compounds.

Physical Form

White to off-white crystalline solid.

Solubility

Sparingly soluble in water, soluble in organic solvents.

Importance

Commonly used in organic chemistry research and is an important intermediate in the production of various drug compounds.

Upstream product

• 771-99-3 4-phenylpiperidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 26905-03-3 4-(4-Nitrophenyl)piperidine 
• 109384-19-2 t-butyl 4-hydroxy piperidine-1-carboxylate 
• 586-78-7 para-nitrophenyl bromide 
• 301673-14-3 tert-butyl 4-iodopiperidine-1-carboxylate 

Downstream Products

• 26905-03-3 4-(4-Nitrophenyl)piperidine 
• 170011-57-1 tert-butyl 4-(4-aminophenyl)piperidin-1-carboxylate 

Relevant articles and documents

Direct synthesis of 4-arylpiperidines via palladium/copper(I)-cocatalyzed negishi coupling of a 4-piperidylzinc iodide with aromatic halides and triflates

A general procedure for the synthesis of 4-arylpiperidines via the coupling of 4-(N-BOC-piperidyl)zinc iodide with aryl halides and triflates is presented. The reaction requires cocatalysis with both Cl2Pd(dppf) and a copper(I) species. An impr

THIENOPYRAZOLE DERIVATIVE HAVING PDE7 INHIBITORY ACTIVITY

To provide thienopyrazole derivatives inhibiting PDE 7 selectively, and therefore, enhance cellular cAMP level. Consequently, the compound is useful for treating various kinds of disease such as allergic diseases, inflammatory diseases or immunologic diseases. The compound is thienopyrazole compound represented by the following formula (I): [wherein, especially, R 1 is a cyclohexyl, a cycloheptyl group or a tetrahydropyranyl group; R 2 is methyl; R 3 is a hydrogen atom; and R 4 is a group: -CONR 5 R 6 (in which any one of R 5 and R 6 is a hydrogen atom)].

QUINOLINE- AND ISOQUINOLINE-BASED COMPOUNDS EXHIBITING ATP-UTILIZING ENZYME INHIBITORY ACTIVITY, AND COMPOSITIONS, AND USES THEREOF

Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, methods of using compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions comprising compounds exhibiting ATP-utilizing enzyme inhibitory activity, are disclosed.